Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies

The outbreak of the COVID-19 pandemic in China has become an urgent health and economic challenge. The objective of the current work was to evaluate the efficacy of the combined complex of Sitagliptin (SIT) with melittin (MEL) against SARS-CoV-2 virus. SIT-MEL nano-conjugates were optimized by a ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rabia, Mohammed W., Alhakamy, Nabil A., Ahmed, Osama A. A., Eljaaly, Khalid, Alaofi, Ahmed L., Mostafa, Ahmed, Asfour, Hani Z., Aldarmahi, Ahmed A., Darwish, Khaled M., Ibrahim, Tarek S., Fahmy, Usama A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025909/
https://www.ncbi.nlm.nih.gov/pubmed/33652894
http://dx.doi.org/10.3390/pharmaceutics13030307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025909/
https://www.ncbi.nlm.nih.gov/pubmed/33652894
http://dx.doi.org/10.3390/pharmaceutics13030307

Ejemplares similares